Successful Rights Issue for HISUN Pharmaceutical

Following more than a year of intense preparation, HISUN Pharmaceuticals has received approval from the Chinese Securities Regulatory Commission for a proposed rights issue of its 'A' shares. The shares were issued on October 29, 2009, with the existing shareholders of 'A' shares given priority in subscribing to the new shares, while the remaining shares were issuing off-line to institutional investors, and online to public investors at fixed price.

A total of 34.5 million shares were issued at the offer price of RMB 19.43, raising a total of RMB 670 million. After deducting expenses, etc., the net amount raised was RMB 650 million. Following the rights issued, the company's total shares stood at 483.78 million shares. Net asset per share stood at RMB 4.

78, and EPS at RMB 0.40.